(Circulation. 1997;96:2520-2525.)
© 1997 American Heart Association, Inc.
Articles |
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction
From the Division of Preventive Medicine (J.M.G., C.H.H., J.E.B.) and the Cardiovascular Division (J.M.G.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; Department of Ambulatory Care and Prevention (J.E.B., C.H.H.), Harvard Medical School, Boston, Mass; Department of Epidemiology (C.H.H., J.E.B.), Harvard School of Public Health, Boston, Mass; Department of Medicine (J.M.G.), Veterans Affairs Medical Center, Brockton/West Roxbury, Mass; Laboratory of Biochemical Genetics and Metabolism (J.L.B.), Rockefeller University, New York, NY; and National Heart, Lung, and Blood Institute (C.J.O.), Framingham Heart Study, Framingham, Mass.
Background Recent data suggest that triglyceride-rich lipoproteins may play a role in atherogenesis. However, whether triglycerides, as a marker for these lipoproteins, represent an independent risk factor for coronary heart disease remains unclear, despite extensive research. Several methodological issues have limited the interpretability of the existing data.
Methods and Results We examined the interrelationships of fasting triglycerides, other lipid parameters, and nonlipid risk factors with risk of myocardial infarction among 340 cases and an equal number of age-, sex-, and community-matched control subjects. Cases were men or women of <76 years of age with no prior history of coronary disease who were discharged from one of six Boston area hospitals with the diagnosis of a confirmed myocardial infarction. In crude analyses, we observed a significant association of elevated fasting triglycerides with risk of myocardial infarction (relative risk [RR] in the highest compared with the lowest quartile=6.8; 95% confidence interval [CI]=3.8 to 12.1; P for trend <.001). Results were not materially altered after control for nonlipid coronary risk factors. As expected, the relationship was attenuated after adjustment for HDL but remained statistically significant (RR in the highest quartile=2.7; 95% confidence interval [CI]=1.4 to 5.5; P for trend=.016). Furthermore, the ratio of triglycerides to HDL was a strong predictor of myocardial infarction (RR in the highest compared with the lowest quartile=16.0; 95% CI=7.7 to 33.1; P for trend <.001).
Conclusions Our data indicate that fasting triglycerides, as a marker for triglyceride-rich lipoproteins, may provide valuable information about the atherogenic potential of the lipoprotein profile, particularly when considered in context of HDL levels.
Key Words: triglycerides • lipoproteins • infarction • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  G. D Brinkworth, M. Noakes, J. D Buckley, J. B Keogh, and P. M Clifton Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo Am. J. Clinical Nutrition, July 1, 2009; 90(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hoeger, K. Davidson, L. Kochman, T. Cherry, L. Kopin, and D. S. Guzick The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4299 - 4306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miller, C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, E. Braunwald, and for the PROVE IT-TIMI 22 Investigators Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 724 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Fernandez and D. Webb The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk J. Am. Coll. Nutr., February 1, 2008; 27(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Zhang, K. E. Bird, T. S. McMillen, R. C. LeBoeuf, T. M. Hagen, and B. Frei Dietary {alpha}-Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor Deficient Mice Circulation, January 22, 2008; 117(3): 421 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M Ridker Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women JAMA, July 18, 2007; 298(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, D. A Faulkner, T. Nguyen, T. Kemp, A. Marchie, J. M. Wong, R. de Souza, A. Emam, E. Vidgen, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia Am. J. Clinical Nutrition, March 1, 2006; 83(3): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh, S. H. Han, M.-S. Shin, J. Y. Ahn, Y. Lee, and E. K. Shin Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study Eur. Heart J., July 2, 2005; 26(14): 1362 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Karelis, M. Faraj, J.-P. Bastard, D. H. St-Pierre, M. Brochu, D. Prud'homme, and R. Rabasa-Lhoret The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4145 - 4150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reaven The Metabolic Syndrome: Requiescat in Pace Clin. Chem., June 1, 2005; 51(6): 931 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Siripaitoon, M Osiri, V Vongthavaravat, S Akkasilpa, and U Deesomchok The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus Lupus, December 1, 2004; 13(12): 961 - 968. [Abstract] [PDF]
|
|
|
|
|
|
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity Clin. Chem., December 1, 2004; 50(12): 2316 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Asia Pacific Cohort Studies Collaboration Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region Circulation, October 26, 2004; 110(17): 2678 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dobiasova Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications Clin. Chem., July 1, 2004; 50(7): 1113 - 1115. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Tan, D. Johns, and N. B. Glazer Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Clin. Chem., July 1, 2004; 50(7): 1184 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark and B. J Holub Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Djousse, S. C Hunt, D. K Arnett, M. A Province, J. H Eckfeldt, and R C. Ellison Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1098 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, and G. Reaven Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant Ann Intern Med, November 18, 2003; 139(10): 802 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh, J. Y. Ahn, D. K. Jin, B.-K. Yoon, H. S. Kim, D. S. Kim, W. C. Kang, S. H. Han, I. S. Choi, and E. K. Shin Significant Differential Effects of Hormone Therapy or Tibolone on Markers of Cardiovascular Disease in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1889 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Johansson, L. Wilhelmsen, G. Lappas, and A. Rosengren High lipid levels and coronary disease in women in Goteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDAstudy Eur. Heart J., April 2, 2003; 24(8): 704 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25-26 August 2002, Washington, DC Diabetes Care, April 1, 2003; 26(4): 1297 - 1303. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Reaven Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight Ann Intern Med, March 4, 2003; 138(5): 420 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Laidlaw and B. J Holub Effects of supplementation with fish oil-derived n-3 fatty acids and {gamma}-linolenic acid on circulating plasma lipids and fatty acid profiles in women Am. J. Clinical Nutrition, January 1, 2003; 77(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Reaven Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease Circulation, July 16, 2002; 106(3): 286 - 288. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Corella, M. Guillen, C. Saiz, O. Portoles, A. Sabater, J. Folch, and J. M. Ordovas Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus J. Lipid Res., March 1, 2002; 43(3): 416 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dewailly, C. Blanchet, S. Lemieux, L. Sauve, S. Gingras, P. Ayotte, and B. J. Holub n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik Am. J. Clinical Nutrition, October 1, 2001; 74(4): 464 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Haidar, S. Mott, B. Boucher, C. Y. Lee, M. Marcil, and J. Genest , Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J. Lipid Res., February 1, 2001; 42(2): 249 - 257. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. P. Kastelein, J. W. Jukema, A. H. Zwinderman, S. Clee, A. J. van Boven, H. Jansen, T. J. Rabelink, R. J. G. Peters, K. I. Lie, G. Liu, et al. Lipoprotein Lipase Activity Is Associated With Severity of Angina Pectoris Circulation, October 3, 2000; 102(14): 1629 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark, E. J Park, V. A Maines, and B. J Holub Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial Am. J. Clinical Nutrition, August 1, 2000; 72(2): 389 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Clee, N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis J. Lipid Res., April 1, 2000; 41(4): 521 - 531. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen Ann Intern Med, September 7, 1999; 131(5): 376 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haim, M. Benderly, D. Brunner, S. Behar, E. Graff, H. Reicher-Reiss, and U. Goldbourt Elevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart Disease : The Bezafibrate Infarction Prevention (BIP) Registry Circulation, August 3, 1999; 100(5): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Fungwe, B. J. Kudchodkar, A. G. Lacko, and L. Dory Fatty Acids Modulate Lecithin:Cholesterol Acyltransferase Secretion Independently of Effects on Triglyceride Secretion in Primary Rat Hepatocytes J. Nutr., August 1, 1998; 128(8): 1270 - 1275. [Abstract] [Full Text]
|
|